BPC-157: What It Is, and What the Evidence Actually Says
BPC-157 is a synthetic fifteen-residue peptide, described as a partial sequence of a protein found in gastric juice. It is usually supplied as the acetate salt, so 10mg on the label is at least 9.22mg of peptide. "Stable BPC-157" is a marketing term rather than a chemical one, and the published research is overwhelmingly preclinical.
BPC-157 is the most searched-for compound in this market and the one most often described in terms the literature does not support. This page covers three things: what the molecule is, what the salt form means for the milligram figure on the label, and what the published research does and does not establish.
The last of those is the part that costs us sales. It is on the page anyway.
Identity#
| Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (GEPPPGKPADDAGLV) |
|---|---|
| Length | 15 residues |
| Molecular formula | C62H98N16O22 (free peptide) |
| Molecular weight | 1419.55 g/mol (free peptide) |
| CAS number | 137525-51-0 |
| Also known as | Body Protection Compound 157; PL 14736; Bepecin |
It is described as a partial sequence of a protein found in gastric juice. That description is accurate and also less meaningful than it sounds: a fifteen-residue fragment of a larger protein is a different molecule from the protein, and a naturally-occurring origin is a statement about where a sequence was first identified, not evidence about what it does.
The salt form, and the number on the label#
Ours is supplied as the acetate salt. BPC-157 has two basic sites that can carry a counter-ion, the free amino end and the lysine at position 7, so the most acetate it can hold is two:
| Free peptide | 1419.55 |
|---|---|
| Acetic acid, ×2 | 120.10 |
| Diacetate salt, at most | 1539.65 |
So 10mg of the salt contains at least 9.22mg of peptide — 92.2%, or more if a lot carries less than two acetates, which is common. Two suppliers can both print “10mg” honestly and ship up to an eight per cent difference in actual compound, depending on which one they weighed.
Our milligram figures refer to the peptide, not the salt. It says so on the product page. That is the more expensive convention. It is also the one worth asking any supplier to state, and most will not have thought about it. The full version of this argument, across several compounds.
“Stable” BPC-157 is a marketing term, not a chemical one#
You will see BPC-157 sold as “stable”, “stabilised” or “stable BPC-157” at a premium. There is no standardised chemical meaning to any of those words here. In practice they usually denote the arginate salt — which is what most BPC-157 on the market already is.
If a supplier charges more for “stable”, ask what is chemically different. A specific answer (“it is the arginate rather than the acetate”) is a real answer. “It is more stable” is not.
What the research actually shows#
This is where most pages about this compound become unreliable, so here is the honest position:
- The published work is overwhelmingly preclinical. The great majority of BPC-157 studies are in rodents, often at doses and by routes that do not translate simply to anything else.
- Much of it comes from a small number of research groups. That is not an accusation of bad work, but independent replication across many groups is one of the things that makes a literature robust, and this one has less of it than its popularity suggests.
- There is no completed, published, adequately-powered human efficacy trial establishing any of the outcomes commonly attributed to it. Claims you will read elsewhere, stated confidently and without citation, are generally extrapolating from animal data.
- It is not a licensed medicine in the United Kingdom, and it is prohibited in sport under the WADA List.
None of that makes it uninteresting. A compound can be genuinely worth studying and simultaneously oversold, and BPC-157 is a clear example of both at once. What it means practically is that anyone buying it is buying a research material with an immature evidence base, and should price their expectations accordingly.
We sell it. We would sell more of it if we wrote the paragraph above differently. We are not going to.
What to check on a certificate#
- Mass near 1419 for the free peptide, or 1594 if the laboratory measured the salt. Either is fine — what matters is that the certificate says which.
- A batch number that matches the vial supplied. A certificate that references no batch is decoration.
- A verification reference you can take to the issuing laboratory. This is the field that makes the others checkable without the supplier's involvement.
Our certificates of analysis are being re-checked, and we are not publishing them or making testing claims until that is finished. Walk-through: how to verify a peptide COA.
Handling and storage#
Supplied lyophilised and stable in transit at ambient temperature, which is why it ships dry. Store the sealed vial at 2–8°C, protected from light. Reconstitute with bacteriostatic or sterile water run down the vial wall, never onto the powder; swirl, do not shake. Keep reconstituted material refrigerated and use it within its stability window. See how to reconstitute research peptides, which solvent to use and how to store them.
Sources#
Each entry links to its PubMed record, where the title and abstract can be read. The descriptions are ours: they say what each paper examined, not what it is claimed to show. Records checked on PubMed on 28 October 2026.
- Sikirić P, Petek M, Rucman R, et al. (1993). J Physiol Paris 87(5):313–27. The Zagreb group’s early overview, introducing the 15-residue fragment and summarising their animal studies. PubMed 8298609
- Chang CH, Tsai WC, Lin MS, et al. (2011). J Appl Physiol (1985) 110(3):774–80. Independent study from Chang Gung University, Taiwan, of rat tendon fibroblasts with BPC-157: outgrowth from tendon explants, cell survival under oxidative stress, and migration. PubMed 21030672
- Gwyer D, Wragg NM, Wilson SL (2019). Cell Tissue Res 377(2):153–159. Review from Loughborough University of the tendon, ligament and muscle studies. Notes that most used small rodent models, that only a handful of groups have studied the peptide, and that its effect in humans is unconfirmed. PubMed 30915550
- He L, Feng D, Guo H, et al. (2022). Front Pharmacol 13:1026182. Pharmacokinetic study in rats and dogs by a group in Xi’an, independent of Zagreb: a half-life under 30 minutes, with the peptide broken down into small fragments and amino acids. PubMed 36588717
- Vasireddi N, Hahamyan H, Salata MJ, et al. (2025). HSS J 21(4):485–495. Systematic review of 36 studies, 35 of them preclinical. Found no clinical safety data, and flags unregulated manufacturing and contamination as risks. PubMed 40756949
- Poolton JT, Minett J, Kazmi A (2026). Acta Orthop Belg 92(3). Systematic review of the human evidence: three small studies with no control group, 30 participants in total, all judged poor quality. Certainty of evidence rated very low. PubMed 42885452
In our catalogue#
- BPC-157 — acetate salt; the milligram figure refers to the peptide
- BPC-157 / TB-500 Blend — Pre-mixed blend (1:1)
- GLOW Blend — BPC-157 + GHK-Cu + TB-500
- KLOW Blend — BPC-157 + GHK-Cu + TB-500 + KPV
- KPV — a three-residue peptide, for contrast on the salt arithmetic
Pioneer Research Peptides — UK supplier of research peptides and laboratory solvents.
For laboratory research use only — not for human consumption. 18+.
Research peptides from UK stock#
Supplied for laboratory research use only. Ask about the documentation for a batch before you order.
